Document d'Enregistrement Universel 2024

Strasbourg, France, May 15, 2025, 05:45 p.m. CEST – The Combined Ordinary and Extraordinary General Meeting of Transgene’s shareholders was held today (May 15, 2025) at 10:00 a.m. at the Company’s...

TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025 Dr. Simone Steiner appointed Chief Technical Officer (CTO)  Business funded until the end of April...